Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of May 2015. The report was filed on May 20, 2015, to disclose a corporate action regarding the company's equity-neutral convertible bonds due 2020.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural notice regarding bond terms rather than a financial performance report.
Material Changes
On May 20, 2015, the Company issued a notice of adjustment to the conversion price and conversion ratio of its equity-neutral convertible bonds due 2020. A copy of this notice is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document strictly addresses the adjustment of bond terms.
Investor Verification Checklist
- Verify the specific details of the conversion price and ratio adjustment in the attached Exhibit 99.1.
- Confirm the impact of this adjustment on the equity-neutral status of the convertible bonds due 2020.
- Review the edited version of the notice to understand any information omitted for U.S. disclosure compliance.